Market Tracker

05/05 6:13am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.435
Delayed Data
As of May 04
 -0.0271 / -5.86%
Today’s Change
0.39
Today|||52-Week Range
6.96
-74.71%
Year-to-Date

Today’s Trading

Previous close0.46
Today’s open0.47
Day’s range0.42 - 0.47
Volume2,750,676
Average volume (3 months)2,155,680
Market cap$67.3M
Dividend yield--
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)+7.69%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...+0.26+7.01%
VCELVericel Corp-0.15-5.15%
CEMIChembio Diagnostics ...+0.08+1.12%
CATBCatabasis Pharmaceut...-0.22-4.91%
Data as of 05/04/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Inside Director
Michael A. Narachi
Chief Commercial Officer &
Executive VP
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts